IMPROVE-IT：一项评价依折麦布/辛伐他汀vs.辛伐他汀临床效能的最大的临床研究（i.e,将辛伐他汀添加到他汀中治疗）非他汀类药物降低LDL-C，依折麦布降低心血管事件吗？是否越低越好？（评价平均LDL-C50vs.65mg）依折麦布的安全性 CannonCPAHJ2008;156:826-32;CaliffRMNEJM2009;361:712-7...
IMPROVE-IT研究幻灯
*MI Genetics Consortium Investigators NEJM 2014; online Nov 12; Ference BA et al AHA 2014 Goal s IMPROVE-IT: First large trial evaluating clinical efficacy of combination EZ/Simva vs. simvastatin (i.e., the addition of ezetimibe to statin therapy): ...
genetic analyses have correlated polymorphisms in NPC1L1 with lower levels of LDL-C and lower risk of CV events* *MI Genetics Consortium Investigators NEJM 2014; online Nov 12; Ference BA et al AHA 2014 Goals IMPROVE-IT: First large trial evaluating clinical efficacy of combination EZ/Simva ...
Improving Safety with Information Technology — NEJM Special Article from The New England Journal of Medicine — Improving Safety with Information Technology LL Leape 被引量: 3176发表: 2003年 If Only We Knew What We Know Includes bibliographical references and index C. Grayson,C O'Dell - Simon ...